Background: Few studies have been carried out on the levels and possible to
xicity of local anesthetics in breast milk after parenteral administration.
The purpose of this study is to determine the amount of lidocaine and its
metabolite monoethylglycinexylidide (MEGX) in breast milk after local anest
hesia during dental procedures.
Methods: The study population consisted of seven nursing mothers (age, 23-3
9 years) who received 3.6 to 7.2 mt 2% lidocaine without adrenaline. Blood
and milk concentrations of lidocaine and its metabolite MEGX were assayed u
sing high performance liquid chromatography. The milk-to-plasma ratio and t
he possible daily doses in infants for both lidocaine and MEGX were calcula
ted.
Results: The lidocaine concentration in maternal plasma 2 hours after injec
tion was 347.6 +/- 221.8 mug/L, the lidocaine concentration in maternal mil
k ranged from 120.5 +/- 54.1 mug/L (3 hours after injection) to 58.3 +/- 22
.8 mug/L (6 hours after injection), the MEGX concentration in maternal plas
ma 2 hours after injection was 58.9 +/- 30.3 mug/L, and the MEGX concentrat
ion in maternal milk ranged from 97.5 +/- 39.6 mug/L (3 hours after injecti
on) to 52.7 +/- 23.8 mug/L (6 hours after injection), According to these da
ta and considering an intake of 90 mL breast milk every 3 hours, the daily
infant dosages of lidocaine and MEGX were 73.41 +/- 38.94 mug/L/day and 66.
1 +/- 28.5 mug/ L/day respectively.
Conclusions: This study suggests that even if a nursing mother undergoes de
ntal treatment with local anesthesia using lidocaine without adrenaline, sh
e can safely continue breastfeeding.